Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
43,666,020
-
Total 13F shares
-
46,828,772
-
Share change
-
+7,737,001
-
Total reported value
-
$1,842,663,442
-
Put/Call ratio
-
97%
-
Price per share
-
$39.35
-
Number of holders
-
140
-
Value change
-
+$358,133,953
-
Number of buys
-
94
-
Number of sells
-
46
Institutional Holders of Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 par value (DNTH) as of Q3 2025
As of 30 Sep 2025,
Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 par value (DNTH) was held by
140 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,828,772 shares.
The largest 10 holders included
FMR LLC, Fairmount Funds Management LLC, Avidity Partners Management LP, RA CAPITAL MANAGEMENT, L.P., WELLINGTON MANAGEMENT GROUP LLP, Octagon Capital Advisors LP, Point72 Asset Management, L.P., TCG Crossover Management, LLC, VANGUARD GROUP INC, and BlackRock, Inc..
This page lists
140
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.